Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.03 $12.11 Wednesday, 8th May 2024 DVAX stock ended at $11.65. This is 0.94% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 1.76% from a day low at $11.64 to a day high of $11.85.
90 days $11.03 $13.27
52 weeks $10.67 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Oct 19, 2016 $10.40 $10.90 $10.20 $10.40 776 200
Oct 18, 2016 $10.40 $10.70 $10.10 $10.35 911 700
Oct 17, 2016 $10.55 $10.55 $10.05 $10.15 738 100
Oct 14, 2016 $10.87 $10.88 $10.31 $10.37 756 400
Oct 13, 2016 $10.55 $10.89 $10.41 $10.82 840 100
Oct 12, 2016 $10.44 $11.47 $10.26 $10.66 1 879 900
Oct 11, 2016 $11.10 $11.20 $10.41 $10.48 945 700
Oct 10, 2016 $10.95 $11.41 $10.90 $11.00 1 006 300
Oct 07, 2016 $11.07 $11.29 $10.55 $10.82 1 491 900
Oct 06, 2016 $11.04 $11.15 $10.60 $10.77 1 247 900
Oct 05, 2016 $10.89 $11.28 $10.62 $11.18 1 491 400
Oct 04, 2016 $12.45 $12.48 $10.67 $10.87 4 273 700
Oct 03, 2016 $11.20 $13.23 $11.11 $12.48 5 830 700
Sep 30, 2016 $10.34 $10.62 $10.11 $10.49 1 285 400
Sep 29, 2016 $11.13 $11.27 $10.30 $10.33 1 676 500
Sep 28, 2016 $10.89 $11.34 $10.67 $11.14 1 991 300
Sep 27, 2016 $11.08 $11.20 $10.73 $10.91 1 338 700
Sep 26, 2016 $11.30 $11.41 $11.02 $11.06 1 487 600
Sep 23, 2016 $11.64 $11.80 $11.40 $11.41 868 500
Sep 22, 2016 $11.77 $12.00 $11.50 $11.62 961 000
Sep 21, 2016 $12.03 $12.18 $11.50 $11.67 1 395 100
Sep 20, 2016 $12.34 $12.38 $12.00 $12.00 725 600
Sep 19, 2016 $12.03 $12.60 $11.87 $12.11 1 312 700
Sep 16, 2016 $11.81 $11.98 $11.61 $11.95 1 180 900
Sep 15, 2016 $11.38 $12.22 $11.28 $11.93 1 893 300
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT